Life seldom gives you opportunities. If taken on time, opportunities give maximum benefits. Whenever, opportunities are not utilised on right time, they become either non beneficial or partially beneficial. You are suffering from obesity and your obesity is in its …

If you thought losing weight was a tedious and tough task, probably you haven’t heard about the gamut of diet pills that are available in the market. Weight loss is something, all obese and over weight individual would do anything …

Life is a competition for survival in which every living being have to beat disease, otherwise disease can beat him. Obesity is accompanied with many fatal diseases like heart attack, kidney failure, arthritis etc. All these diseases make life span …

Our body is the most complicated machinery which nature has ever created. There is a perfect coordination among all systems of the body. Nature has enabled human beings to accumulate fat beneath the skin which is there to provide them …

Obesity is becoming a cosmopolitan problem. It has created some major health related hazards globally like diabetes, chronic heart diseases, high blood pressure etc. In some nations like US and UK, it is a prevailing disease among both adults and …

Obesity is becoming the most common nutritional disorder in many industrialised country around the world. In countries like America and Europe it has reached epidemic levels. Furthermore, oflate there is an alarming rate of child obesity. This growing prevalence of …

IF anecdotes and ancient medicine are to be trusted, cannabis is a wonder drug. Yet results of clinical trials have been mixed and its use in modern medicine remains limited. Now it seems the reasons may be practical as much …

A new obesity wonder drug, Acomplia (rimonabant), makes patients lose 10% of their body weight, according to clinical trials carried out by Sanofi-Aventis, the third largest pharmaceutical company in the world.

Sanofi-Aventis are hoping to have this drug on the market …

Additional beneficial effects on ‘cardiometabolic risk factors’ beyond those expected from weight loss in trials of the anti-obesity drug rimonabant may not be due to the drug itself, reports an article in the June issue of Drug and Therapeutics Bulletin …

Overweight or obese people who are stout around the waist and abdomen are particularly at high risk for developing type 2 diabetes and high blood pressure. The most effective way to reduce blood pressure and the risk for secondary diseases …